Skip to main content
Erschienen in: Infection 5/2015

01.10.2015 | Brief Report

Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease

verfasst von: Micaela Brandolini, Marta Corbella, Annalisa De Silvestri, Carmine Tinelli, Giulia Albonico, Riccardo Albertini, Serena Ludovisi, Raffaele Bruno, Piero Marone, Lorenzo Minoli, Elena Seminari

Erschienen in: Infection | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Observational retrospective study to evaluate the etiology, the outcome and the risk factors of bloodstream infections (BSIs) in patients with liver disease. One hundred and forty-eight BSIs were diagnosed (infection rate: 0.60 per 100 days of hospital stay), 62 BSIs (41.9 %) were associated with Gram-positive bacteria (infection rate: 0.25 per 100 days of hospital stay) and 80 (54.4 %) with Gram-negative bacteria (infection rate: 0.32 per 100 days of hospital stay). Admission-associated mortality was higher in patients with BSI than in those without BSI (20.6 versus 5.0 %, p < 0.001). Patients with cirrhosis had an increased risk to develop a BSI compared with patients with chronic hepatitis, specifically for Gram-positive (and Staphylococcus spp)-related BSI.
Literatur
1.
Zurück zum Zitat Mellencamp MA, Preheim LC. Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae. J Infect Dis. 1991;163(1):102–8.CrossRefPubMed Mellencamp MA, Preheim LC. Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae. J Infect Dis. 1991;163(1):102–8.CrossRefPubMed
2.
Zurück zum Zitat Christou L, Pappas G, Falagas ME. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol. 2007;102(7):1510–7.CrossRefPubMed Christou L, Pappas G, Falagas ME. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol. 2007;102(7):1510–7.CrossRefPubMed
3.
Zurück zum Zitat Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310–24.CrossRefPubMed Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310–24.CrossRefPubMed
4.
5.
Zurück zum Zitat Park HJ, Lee YM, Bang KM, Park SY, Moon SM, Park KH, et al. Clinical significance of Staphylococcus aureus bacteremia in patients with liver cirrhosis. Eur J ClinMicrobiol Infect Dis. 2012;31(12):3309–16.CrossRef Park HJ, Lee YM, Bang KM, Park SY, Moon SM, Park KH, et al. Clinical significance of Staphylococcus aureus bacteremia in patients with liver cirrhosis. Eur J ClinMicrobiol Infect Dis. 2012;31(12):3309–16.CrossRef
6.
Zurück zum Zitat Kuo CH, Changchien CS, Yang CY, Sheen IS, Liaw YF, et al. Bacteremia in patients with cirrhosis of the liver. Liver. 1991;11(6):334–9.CrossRefPubMed Kuo CH, Changchien CS, Yang CY, Sheen IS, Liaw YF, et al. Bacteremia in patients with cirrhosis of the liver. Liver. 1991;11(6):334–9.CrossRefPubMed
7.
Zurück zum Zitat Kang CI, Song JH, Chung DR, Peck KR, Yeom JS, Ki HK, et al. Liver cirrhosis as a risk factor for mortality in a national cohort of patients with bacteremia. J Infect. 2011;63(5):336–43.CrossRefPubMed Kang CI, Song JH, Chung DR, Peck KR, Yeom JS, Ki HK, et al. Liver cirrhosis as a risk factor for mortality in a national cohort of patients with bacteremia. J Infect. 2011;63(5):336–43.CrossRefPubMed
8.
Zurück zum Zitat Bartoletti M, Giannella M, Caraceni P, Domenicali M, Ambretti S, Tedeschi S, et al. Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. J Hepatol. 2014;61(1):51–8.CrossRefPubMed Bartoletti M, Giannella M, Caraceni P, Domenicali M, Ambretti S, Tedeschi S, et al. Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. J Hepatol. 2014;61(1):51–8.CrossRefPubMed
9.
Zurück zum Zitat Fernández Guerrero ML. González López J, Górgolas M. Infectious endocarditis in patients with cirrhosis of the liver: a model of infection in the frail patient. Eur J ClinMicrobiol. Infect Dis. 2010;29(10):1271–5. Fernández Guerrero ML. González López J, Górgolas M. Infectious endocarditis in patients with cirrhosis of the liver: a model of infection in the frail patient. Eur J ClinMicrobiol. Infect Dis. 2010;29(10):1271–5.
10.
Zurück zum Zitat Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–26.CrossRefPubMed Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–26.CrossRefPubMed
11.
Zurück zum Zitat Sheth M, Riggs M, Patel T. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol. 2002;2:2.PubMedCentralCrossRefPubMed Sheth M, Riggs M, Patel T. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol. 2002;2:2.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;29(338):b2393.CrossRef Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;29(338):b2393.CrossRef
13.
Zurück zum Zitat Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Predictive scoring model of mortality in Gram-negative bloodstream infection. Clin Microbiol Infect. 2013;19(10):948–54.CrossRefPubMed Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Predictive scoring model of mortality in Gram-negative bloodstream infection. Clin Microbiol Infect. 2013;19(10):948–54.CrossRefPubMed
14.
Zurück zum Zitat Linderoth G, Jepsen P, Schønheyder HC, Johnsen SP, Sørensen HT. Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: A population-based cohort study. Alcohol ClinExp Res. 2006;30(4):636–41.CrossRef Linderoth G, Jepsen P, Schønheyder HC, Johnsen SP, Sørensen HT. Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: A population-based cohort study. Alcohol ClinExp Res. 2006;30(4):636–41.CrossRef
15.
Zurück zum Zitat Thulstrup AM, Sørensen HT, Schønheyder HC, Møller JK, Tage-Jensen U. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis. 2000;31(6):1357–61.CrossRefPubMed Thulstrup AM, Sørensen HT, Schønheyder HC, Møller JK, Tage-Jensen U. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis. 2000;31(6):1357–61.CrossRefPubMed
16.
Zurück zum Zitat Campillo B, Richardet JP, Kheo T, Dupeyron C. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis. 2002;35(1):1–10.CrossRefPubMed Campillo B, Richardet JP, Kheo T, Dupeyron C. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis. 2002;35(1):1–10.CrossRefPubMed
17.
Zurück zum Zitat Runyon BA. Monomicrobial non neutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology. 1990;12:710–5.CrossRefPubMed Runyon BA. Monomicrobial non neutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology. 1990;12:710–5.CrossRefPubMed
18.
Zurück zum Zitat Kuo CHL, Changchien CS, Yang CY, Sheen IS, Liaw YF. Bacteremia in patients with cirrhosis of the liver. Liver. 1991;11(6):334–9.CrossRefPubMed Kuo CHL, Changchien CS, Yang CY, Sheen IS, Liaw YF. Bacteremia in patients with cirrhosis of the liver. Liver. 1991;11(6):334–9.CrossRefPubMed
19.
Zurück zum Zitat Caly WRL, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 1993;18(3):353–8.CrossRefPubMed Caly WRL, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 1993;18(3):353–8.CrossRefPubMed
20.
Zurück zum Zitat Kang CI, Song JH, Ko KS, Chung DR, Peck KR. Clinical significance of Staphylococcus aureus infection in patients with chronic liver diseases. Liver Int. 2010;30(9):1333–8.CrossRefPubMed Kang CI, Song JH, Ko KS, Chung DR, Peck KR. Clinical significance of Staphylococcus aureus infection in patients with chronic liver diseases. Liver Int. 2010;30(9):1333–8.CrossRefPubMed
21.
Zurück zum Zitat Squier C, Rihs JD, Risa KJ, Sagnimeni A, Wagener MM, Stout J, et al. Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol. 2002;23(9):495–501.CrossRefPubMed Squier C, Rihs JD, Risa KJ, Sagnimeni A, Wagener MM, Stout J, et al. Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol. 2002;23(9):495–501.CrossRefPubMed
22.
Zurück zum Zitat Paterson DL, Rihs JD, Squier C, Gayowski T, Marino IR, Sagnemeni A, et al. Lack of efficacy of mupirocin in the prevention of infections with methicillin-resistant Staphylococcus aureus in liver transplant recipients and candidates. Transplantation. 2003;75:194–8.CrossRefPubMed Paterson DL, Rihs JD, Squier C, Gayowski T, Marino IR, Sagnemeni A, et al. Lack of efficacy of mupirocin in the prevention of infections with methicillin-resistant Staphylococcus aureus in liver transplant recipients and candidates. Transplantation. 2003;75:194–8.CrossRefPubMed
23.
Zurück zum Zitat Dupeyron C, Campillo B, Richardet JP, Soussy CJ. Long-term efficacy of mupirocin in the prevention of infections with methicillin-resistant Staphylococcus aureus in a gastroenterology unit. J Hosp Infect. 2006;63(4):385–92.CrossRefPubMed Dupeyron C, Campillo B, Richardet JP, Soussy CJ. Long-term efficacy of mupirocin in the prevention of infections with methicillin-resistant Staphylococcus aureus in a gastroenterology unit. J Hosp Infect. 2006;63(4):385–92.CrossRefPubMed
24.
Zurück zum Zitat Falcone M, Concia E, Iori I, Lo Cascio G, Mazzone A, Pea F, et al. Identification and management of invasive mycoses in internal medicine: a road-map for physicians. Intern Emerg Med. 2014;9(5):501–11.CrossRefPubMed Falcone M, Concia E, Iori I, Lo Cascio G, Mazzone A, Pea F, et al. Identification and management of invasive mycoses in internal medicine: a road-map for physicians. Intern Emerg Med. 2014;9(5):501–11.CrossRefPubMed
25.
Zurück zum Zitat Leber B, Spindelboeck W, Stadlbauer V. Infectious complications of acute and chronic liver disease. SeminRespirCrit Care Med. 2012;33(1):80–95. Leber B, Spindelboeck W, Stadlbauer V. Infectious complications of acute and chronic liver disease. SeminRespirCrit Care Med. 2012;33(1):80–95.
26.
Zurück zum Zitat Hung TH, Hsieh YH, Tseng KC, Tsai CC, Tsai CC. The risk for bacterial endocarditis in cirrhotic patients: a population-based 3-year follow-up study. Int J Infect Dis. 2013;17(6):e391–3.CrossRefPubMed Hung TH, Hsieh YH, Tseng KC, Tsai CC, Tsai CC. The risk for bacterial endocarditis in cirrhotic patients: a population-based 3-year follow-up study. Int J Infect Dis. 2013;17(6):e391–3.CrossRefPubMed
27.
Zurück zum Zitat Fernández Guerrero ML. González López J, Górgolas M. Infectious endocarditis in patients with cirrhosis of the liver: a model of infection in the frail patient. Eur J Clin Microbiol Infect Dis. 2010;29(10):1271–5.CrossRefPubMed Fernández Guerrero ML. González López J, Górgolas M. Infectious endocarditis in patients with cirrhosis of the liver: a model of infection in the frail patient. Eur J Clin Microbiol Infect Dis. 2010;29(10):1271–5.CrossRefPubMed
Metadaten
Titel
Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease
verfasst von
Micaela Brandolini
Marta Corbella
Annalisa De Silvestri
Carmine Tinelli
Giulia Albonico
Riccardo Albertini
Serena Ludovisi
Raffaele Bruno
Piero Marone
Lorenzo Minoli
Elena Seminari
Publikationsdatum
01.10.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 5/2015
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-015-0794-6

Weitere Artikel der Ausgabe 5/2015

Infection 5/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.